Related Experiment Videos
Genetic markers in familial narcolepsy.
W C Orr1, J A Othman, O H Rundell
1Baptist Medical Center, Presbyterian Hospital, Oklahoma City, Oklahoma.
Sleep
|June 1, 1991
Summary
This study investigated a family with excessive daytime sleepiness and cataplexy. Unexpectedly, all patients lacked the HLA-DR2 antigen, typically associated with narcolepsy.
Area of Science:
- Neurology
- Sleep Medicine
- Genetics
Background:
- Narcolepsy is a chronic neurological disorder affecting the brain's ability to regulate sleep-wake cycles.
- Key symptoms include excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations.
- The HLA-DR2 antigen is a well-established genetic marker associated with narcolepsy.
Purpose of the Study:
- To investigate the clinical and genetic profile of a family presenting with narcolepsy-like symptoms.
- To determine the association of HLA-DR2 antigen status with narcolepsy in this familial cohort.
Main Methods:
- Clinical evaluation of three family members (father and two sons) with reported sleep disorders.
- Multiple Sleep Latency Tests (MSLT) to objectively measure sleepiness and sleep onset patterns.
- Histocompatibility antigen typing, specifically for HLA-DR2.
Main Results:
- All three patients exhibited excessive daytime sleepiness, hypnagogic hallucinations, and sleep paralysis.
- Two patients presented with cataplexy.
- MSLT results showed extremely short sleep onset latencies and multiple sleep-onset rapid eye movement periods.
- All patients were negative for the HLA-DR2 antigen.
Conclusions:
- The findings suggest a potential narcolepsy diagnosis in this family, despite the absence of the typical HLA-DR2 marker.
- This case highlights the possibility of narcolepsy occurring in HLA-DR2 negative individuals, particularly within familial contexts.
- Further research into the genetic underpinnings of narcolepsy in HLA-DR2 negative populations is warranted.